Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
D000367:Age Factors; D000368:Aged; D002747:Chlorpropamide / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000150:complications; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D009765:Obesity; D010629:Phenformin / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis
D007328:Insulin; D010629:Phenformin; D002747:Chlorpropamide